Drug Target Review – Issue #3 2017

Posted: 6 September 2017 | | No comments yet

Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer’s disease; Accelerating neuroscience research with flow cytometry…

Drug Target Review issue 3 2017
  • Foreword: The importance of industry partnerships
    Chris Watkins, Director of Innovation, Medical Research Council
  • In-Depth Focus: Assays
  • Research Area: Alzheimer’s Disease – Calcilytics as potential novel therapeutic treatments to halt Alzheimer’s disease
    Anna Chiarini, Ubaldo Armato and Ilaria Dal Prà, University of Verona
  • In-Depth Focus: Imaging
  • Stem Cells: EUTCD-Grade lines – an innovative approach to creating and supplying clinical hESC lines
    Glyn Stacey, UK Stem Cell Bank
  • Flow Cytometry: accelerating neuroscience research
    Pushpanathan Muthuirulan, National Institute of Health
  • In-Depth Focus: NGS


The digital version of issue #3 2017 is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here